Tonix Pharmaceuticals (TNXP) Reports Q3 Loss of $0.29/Share

Go back to Tonix Pharmaceuticals (TNXP) Reports Q3 Loss of $0.29/Share

Form 10-Q Tonix Pharmaceuticals For: Sep 30

November 10, 2016 4:09 PM EST

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

... More

Form 8-K Tonix Pharmaceuticals For: Nov 10

November 10, 2016 7:06 AM EST

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More